Journal of the American Society of Hypertension
Volume 1, Issue 5 , Pages 353-361 , September 2007

Increased blood pressure, vascular inflammation, and endothelial dysfunction in androgen-deficient follitropin receptor knockout male mice

  • Danesh Javeshghani, DVM, PhD

      Affiliations

    • Molecular Reproductive Research Laboratories, Clinical Research Institute of Montreal, Quebec, Canada
    • Vascular and Hypertension Research Unit, SMBD Jewish General Hospital, Montreal, Quebec, Canada
    • Kidney Research Centre, Ottawa Health Research Institute, University of Ottawa, Ontario, Canada
    • Dr. Javeshghani is the recipient of a fellowship from the Heart and Stroke Foundation of Canada.
    • ,
  • M. Ram Sairam, PhD

      Affiliations

    • Molecular Reproductive Research Laboratories, Clinical Research Institute of Montreal, Quebec, Canada
    • ,
  • Ernesto L. Schiffrin, MD, FRCP, PhD

      Affiliations

    • Molecular Reproductive Research Laboratories, Clinical Research Institute of Montreal, Quebec, Canada
    • ,
  • Rhian M. Touyz, MD, PhD

      Affiliations

    • Molecular Reproductive Research Laboratories, Clinical Research Institute of Montreal, Quebec, Canada
    • Corresponding Author InformationCorresponding author: Rhian M. Touyz, MD, PhD, Kidney Research Centre, OHRI/University of Ottawa, 451 Smyth Road, Ottawa, K1H 8M5, Ontario, Canada. Tel: 613-562-5800 (ext. 8241); fax: 613-562-5487.

Received 14 March 2007 ,Accepted 6 June 2007.

References 

  1. Wu FC, von Eckardstein A. Androgens and coronary artery disease. Endocr Rev. 2003;24:183–217
  2. Kalin MF, Zumoff B. Sex hormones and coronary disease: a review of the clinical studies. Steroids. 1990;55:330–332
  3. English KM, Mandour O, Steeds RP, Diver MJ, Jones TH, Channer KS. Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms. Eur Heart J. 2000;21:890–894
  4. Iliescu R, Cucchiarelli VE, Yanes LL, Iles JW, Reckelhoff JF. Impact of androgen-induced oxidative stress on hypertension in male SHR. Am J Physiol Regul Integr Comp Physiol. 2007;292:R731–R735
  5. Jones RD, Hugh JT, Channer KS. The influence of testosterone upon vascular reactivity. Eur J Endocrinol. 2004;151:29–37
  6. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340:115–126
  7. Shimokawa H. Primary endothelial dysfunction: atherosclerosis. J Mol Cell Cardiol. 1999;31:23–37
  8. Ross R. Atherosclerosis is an inflammatory disease. Am Heart J. 1999;138:S419–S420
  9. Alexandersen P, Christiansen C. The aging male: testosterone deficiency and testosterone replacement: an up-date. Atherosclerosis. 2004;173:157–169
  10. Dierich A, Sairam MR, Monaco L, Fimia GM, Gansmuller A, LeMeur M, et al. Impairing follicle-stimulating hormone (FSH) signaling in vivo: targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance. Proc Natl Acad Sci U S A. 1998;95:13612–13617
  11. Reckelhoff JF. Sex steroids, cardiovascular disease, and hypertension: unanswered questions and some speculations. Hypertension. 2005;45:170–174
  12. Cushing SD, Fogelman AM. Monocytes may amplify their recruitment into inflammatory lesions by inducing monocyte chemotactic protein. Arterioscler Thromb Vasc Biol. 1992;12:78–82
  13. Mendelsohn ME. Protective effects of estrogen on the cardiovascular system. Am J Cardiol. 2002;89:12E–17E
  14. Krishnamurthy H, Kats R, Danilovich N, Javeshghani D, Sairam MR. Intercellular communication between Sertoli cells and Leydig cells in the absence of follicle-stimulating hormone-receptor signaling. Biol Reprod. 2001;65:1201–1207
  15. Krishnamurthy H, Babu PS, Morales CR, Sairam MR. Delay in sexual maturity of the follicle-stimulating hormone receptor knockout male mouse. Biol Reprod. 2001;65:522–531
  16. Mills PA, Huetteman DA, Brockway BP, Zwiers LM, Gelsema AJ, Schwartz RS, et al. A new method for measurement of blood pressure, heart rate, and activity in the mouse by radiotelemetry. J Appl Physiol. 2000;88:1537–1544
  17. Schiffrin EL, Park JB, Intengan HD, Touyz RM. Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan. Circulation. 2000;101:1653–1659
  18. Xing W, Krishnamurthy H, Sairam MR. Role of follitropin receptor signaling in nuclear protein transitions and chromatin condensation during spermatogenesis. Biochem Biophys Res Commun. 2003;312:697–701
  19. Svartberg J, von Muhlen D, Schirmer H, Barrett-Connor E, Sundfjord J, Jorde R. Association of endogenous testosterone with blood pressure and left ventricular mass in men: the Tromso Study. Eur J Endocrinol. 2004;150:65–71
  20. Aalkjaer C, Heagerty AM, Petersen KK, Swales JD, Mulvany MJ. Evidence for increased media thickness, increased neuronal amine uptake, and depressed excitation—contraction coupling in isolated resistance vessels from essential hypertensives. Circ Res. 1987;61:181–186
  21. Izzard AS, Heagerty AM. Impaired flow-dependent dilatation in distal mesenteric arteries from the spontaneously hypertensive rat. J Physiol. 1999;518:239–245
  22. Franklin SS, Gustin WIV, Wong ND, Larson MG, Weber LA, Kannel WB, et al. Hemodynamic patterns of age-related changes in blood pressure: the Framingham Heart Study. Circulation. 1997;96:308–315
  23. Wang J-G, Staessen JA, Franklin SS, Fagard R, Gueyffier F. Systolic and diastolic blood pressure lowering as determinants of cardiovascular outcome. Hypertension. 2005;45:907–913
  24. Ikeda Y, Aihara K, Sato T, Akaike M, Yoshizumi M, Suzaki Y, et al. Androgen receptor gene knockout male mice exhibit impaired cardiac growth and exacerbation of angiotensin II-induced cardiac fibrosis. J Biol Chem 2005l;280:29661–6.
  25. Kaganovsky E, Belkin V, Barhum Y, Schaper J, Schaper W, Kessler-Icekson G. Occurrence and distribution of atrial natriuretic peptide-containing cells in the left ventricle of hypertensive rats (Effect of antihypertensive treatment). Cell Tissue Res. 2001;303:57–67
  26. Muller M, van den Beld AW, Bots ML, Grobbee DE, Lamberts SW, van der Schouw YT. Endogenous sex hormones and progression of carotid atherosclerosis in elderly men. Circulation. 2004;109:2074–2079
  27. Kang SM, Jang Y, Kim JY, Chung N, Cho SY, Chae JS, et al. Effect of oral administration of testosterone on brachial arterial vasoreactivity in men with coronary artery disease. Am J Cardiol. 2002;89:862–864
  28. McGuire JJ, Ding H, Triggle CR. Endothelium-derived relaxing factors: a focus on endothelium-derived hyperpolarizing factor(s). Can J Physiol Pharmacol. 2001;79:443–470
  29. Darblade B, Pendaries C, Krust A, Dupont S, Fouque MJ, Rami J, et al. Estradiol alters nitric oxide production in the mouse aorta through the alpha-, but not beta-, estrogen receptor. Circ Res. 2002;90:413–419
  30. Meyer MR, Haas E, Barton M. Gender differences of cardiovascular disease: new perspectives for estrogen receptor signaling. Hypertension. 2006;47:1019–1026
  31. Aavik E, du Toit D, Myburgh E, Frosen J, Hayry P. Estrogen receptor-beta dominates in baboon carotid after endothelial denudation injury. Mol Cell Endocrinol. 2001;182:91–98
  32. Lindner V, Kim SK, Karas RH, Kuiper GG, Gustafsson JA, Mendelsohn ME. Increased expression of estrogen receptor-beta mRNA in male blood vessels after vascular injury. Circ Res. 1998;83:224–229
  33. Villablanca A, Lubahn D, Shelby L, Lloyd K, Barthold S. Susceptibility to early atherosclerosis in male mice is mediated by estrogen receptor-alpha. Arterioscler Thromb Vasc Biol. 2004;24:1055–1061
  34. Leung PS, Wong TP, Chung YW, Chan HC. Androgen dependent expression of AT1 receptor and its regulation of anion secretion in rat epididymis. Cell Biol Int. 2002;26:117–122
  35. Song J, Kost CK, Martin DS. Androgens augment renal vascular responses to ANG II in New Zealand genetically hypertensive rats. Am J Physiol Regul Integr Comp Physiol. 2006;290:R1608–R1615

 This study was supported by Grants 44018 (R.M.T.), 13570 (E.L.S.), and a grant to the Multidisciplinary Research Group on Hypertension, all from the Canadian Institutes of Health Research.

 Conflict of interest: none.

PII: S1933-1711(07)00129-5

doi: 10.1016/j.jash.2007.06.003

Journal of the American Society of Hypertension
Volume 1, Issue 5 , Pages 353-361 , September 2007

Article Tools

* Image Usage & Resolution